A phase I trial of an HLA-A1 restricted MAGE-3 epitope peptide with incomplete freund’s adjuvant in patients with resected high-risk melanoma

  • Jeffrey S. Weber
  • , Flora L. Hua
  • , Lucy Spears
  • , Verna Marty
  • , Catherine Kuniyoshi
  • , Esteban Celis

Research output: Contribution to journalArticlepeer-review

122 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I trial of an HLA-A1 restricted MAGE-3 epitope peptide with incomplete freund’s adjuvant in patients with resected high-risk melanoma'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology